FibroBiologics, Inc. - Common Stock Q2 EPS $(0.66) Beats $(0.72) Estimate
Fibrobiologics Inc FBLG
$0.70
▼ -2.67%
($-0.02)
🎈 Low Float
Open
$0.74
Prev Close
$0.72
Day Range
$0.68 – $0.74
52W Range
$0.62 – $13.16
Market Cap
$4.26M
Beta
1.25
EPS (TTM)
$-5.21
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-01-31 |
| Shares Out. | 6,080,000 |
| Website | fibrobiologics.com/ ↗ |
| Phone | 12816715150 |
| Employees | 15 |
| Net Income | -$5.0M |
| Free Cash Flow | -$15.7M |
| Total Assets | $5.9M |
| Total Liabilities | $3.3M |
| Equity | $2.6M |
About Fibrobiologics Inc
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Fibrobiologics Inc is a publicly traded company under the ticker symbol FBLG on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)